<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15(3)</volume><submitter>Oktem RM</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Hyperphenylalaninemia (HPA) is defined as blood phenylalanine (Phe) levels exceeding the normal values (>120 μmol/L or >2 mg/dL) and is caused by a deficiency in the enzyme phenylalanine hydroxylase (PAH). The widespread screening of Phe levels in newborn screening programs has led to a very high number of patients with HPA.&lt;h4>Methods&lt;/h4>The samples were collected at various ages, not at the point of diagnosis. Nine pterin derivatives, including isoxanthopterin, sepiapterin, xanthopterin, primapterin, biopterin, neopterin, 7,8-dihydrobiopterin, 7,8-dihydroneopterin, and tetrahydrobiopterin (BH4), were analyzed in different HPA classes in serum, dried blood spots (DBS), and urine samples. A total of 18 patients, including six classical phenylketonuria (PKU), eight BH4-r</pubmed_abstract><journal>Molecular syndromology</journal><pagination>185-193</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11149980</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Pterin Profiling in Serum, Dried Blood Spot, and Urine Samples Using LC-MS/MS in Patients with Inherited Hyperphenylalaninemia.</pubmed_title><pmcid>PMC11149980</pmcid><pubmed_authors>Oktem RM</pubmed_authors><pubmed_authors>Inci A</pubmed_authors><pubmed_authors>Bayrak H</pubmed_authors><pubmed_authors>Mavis ME</pubmed_authors><pubmed_authors>Yılmaz H</pubmed_authors><pubmed_authors>Ezgu FS</pubmed_authors><pubmed_authors>Gursu GG</pubmed_authors><pubmed_authors>Tumer L</pubmed_authors><pubmed_authors>Demir F</pubmed_authors><pubmed_authors>Okur I</pubmed_authors><pubmed_authors>Biberoglu G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Pterin Profiling in Serum, Dried Blood Spot, and Urine Samples Using LC-MS/MS in Patients with Inherited Hyperphenylalaninemia.</name><description>&lt;h4>Background&lt;/h4>Hyperphenylalaninemia (HPA) is defined as blood phenylalanine (Phe) levels exceeding the normal values (>120 μmol/L or >2 mg/dL) and is caused by a deficiency in the enzyme phenylalanine hydroxylase (PAH). The widespread screening of Phe levels in newborn screening programs has led to a very high number of patients with HPA.&lt;h4>Methods&lt;/h4>The samples were collected at various ages, not at the point of diagnosis. Nine pterin derivatives, including isoxanthopterin, sepiapterin, xanthopterin, primapterin, biopterin, neopterin, 7,8-dihydrobiopterin, 7,8-dihydroneopterin, and tetrahydrobiopterin (BH4), were analyzed in different HPA classes in serum, dried blood spots (DBS), and urine samples. A total of 18 patients, including six classical phenylketonuria (PKU), eight BH4-r</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jun</publication><modification>2025-04-18T16:01:25.133Z</modification><creation>2025-04-07T02:58:30.071Z</creation></dates><accession>S-EPMC11149980</accession><cross_references><pubmed>38841329</pubmed><doi>10.1159/000535853</doi></cross_references></HashMap>